Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis-Reference-Cited by-同舟云学术

Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis

Published:2022-11 Issue: Volume:Volume 15 Page:959-965
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Igumnova Viktorija,Kivrane Agnija,Viksna Anda,Norvaisa Inga,Ranka Renate^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference23 articles.

1. Stanford University and St. Jude Children’s Research Hospital. Clinical pharmacogenetics implementation consortium guidelines. Available from: https://cpicpgx.org/guidelines/. Accessed October 31, 2022.

2. Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects

3. Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation

4. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

5. The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships;Frontiers in Pharmacology;2024-03-22

2. Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective;Pharmaceutics;2024-03-12